Literature DB >> 30820778

Pro- and antitumor effects of mitochondrial reactive oxygen species.

Valéry L Payen1,2,3, Luca X Zampieri1, Paolo E Porporato4, Pierre Sonveaux5.   

Abstract

In cancer, mitochondrial functions are commonly altered. Directly involved in metabolic reprogramming, mitochondrial plasticity confers to cancer cells a high degree of adaptability to a wide range of stresses and to the harsh tumor microenvironment. Lack of nutrients or oxygen caused by altered perfusion, metabolic needs of proliferating cells, co-option of the microenvironment, control of the immune system, cell migration and metastasis, and evasion of exogenous stress (e.g., chemotherapy) are all, at least in part, influenced by mitochondria. Mitochondria are undoubtedly one of the key contributors to cancer development and progression. Understanding their protumoral (dys)functions may pave the way to therapeutic strategies capable of turning them into innocent entities. Here, we will focus on the production and detoxification of mitochondrial reactive oxygen species (mtROS), on their impact on tumorigenesis (genetic, prosurvival, and microenvironmental effects and their involvement in autophagy), and on tumor metastasis. We will also summarize the latest therapeutic approaches involving mtROS.

Entities:  

Keywords:  Antioxidants; Cancer; Mitochondria; Mitochondrial reactive oxygen species (mtROS); Pro-oxidants; mitoQ

Mesh:

Substances:

Year:  2019        PMID: 30820778     DOI: 10.1007/s10555-019-09789-2

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  6 in total

Review 1.  mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer.

Authors:  Karen Griselda de la Cruz López; Mariel Esperanza Toledo Guzmán; Elizabeth Ortiz Sánchez; Alejandro García Carrancá
Journal:  Front Oncol       Date:  2019-12-13       Impact factor: 6.244

Review 2.  The Impact of Mitochondrial Fission-Stimulated ROS Production on Pro-Apoptotic Chemotherapy.

Authors:  Jan Ježek; Katrina F Cooper; Randy Strich
Journal:  Biology (Basel)       Date:  2021-01-06

3.  Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex.

Authors:  Ying Liu; Shiting Yu; Xin Xing; Juhui Qiao; Yiqiu Yin; Jiawen Wang; Meichen Liu; Wei Zhang
Journal:  Mol Med Rep       Date:  2021-10-29       Impact factor: 2.952

Review 4.  Hypoxia Signaling in Cancer: From Basics to Clinical Practice.

Authors:  Anna Sebestyén; László Kopper; Titanilla Dankó; József Tímár
Journal:  Pathol Oncol Res       Date:  2021-05-03       Impact factor: 3.201

5.  MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity.

Authors:  Tania Capeloa; Joanna Krzystyniak; Donatienne d'Hose; Amanda Canas Rodriguez; Valery L Payen; Luca X Zampieri; Justine A Van de Velde; Zohra Benyahia; Erica Pranzini; Thibaut Vazeille; Maude Fransolet; Caroline Bouzin; Davide Brusa; Carine Michiels; Bernard Gallez; Michael P Murphy; Paolo E Porporato; Pierre Sonveaux
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

6.  MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice.

Authors:  Tania Capeloa; Joanna Krzystyniak; Amanda Canas Rodriguez; Valéry L Payen; Luca X Zampieri; Erica Pranzini; Françoise Derouane; Thibaut Vazeille; Caroline Bouzin; François P Duhoux; Michael P Murphy; Paolo E Porporato; Pierre Sonveaux
Journal:  Cancers (Basel)       Date:  2022-03-15       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.